Biopsy Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Biopsy Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Biopsy Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Biopsy entails the removal of some tissue from the body for the purpose of diagnosis or for its examination under a microscope. A Biopsy Device is an instrument that aids in the removal of tissue samples from the body.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Biopsy Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Biopsy Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Biopsy Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Biopsy Devices Overview
Products under Development
Biopsy Devices - Pipeline Products by Stage of Development
Table Biopsy Devices - Pipeline Products by Stage of Development
Table Biopsy Devices - Pipeline Products by Stage of Development
Biopsy Devices - Pipeline Products by Segment
Table Biopsy Devices - Pipeline Products by Segment
Table Biopsy Devices - Pipeline Products by Segment
Biopsy Devices - Pipeline Products by Territory
Table Biopsy Devices - Pipeline Products by Territory
Table Biopsy Devices - Pipeline Products by Territory
Biopsy Devices - Pipeline Products by Regulatory Path
Table Biopsy Devices - Pipeline Products by Regulatory Path
Table Biopsy Devices - Pipeline Products by Regulatory Path
Biopsy Devices - Pipeline Products by Estimated Approval Date
Table Biopsy Devices - Pipeline Products by Estimated Approval Date
Table Biopsy Devices - Pipeline Products by Estimated Approval Date
Biopsy Devices - Ongoing Clinical Trials
Table Biopsy Devices - Ongoing Clinical Trials
Table Biopsy Devices - Ongoing Clinical Trials
Biopsy Devices - Pipeline Products under Development by Companies
Biopsy Devices Companies - Pipeline Products by Stage of Development
Table Biopsy Devices Companies - Pipeline Products by Stage of Development
Biopsy Devices - Pipeline Products by Stage of Development
Table Biopsy Devices - Pipeline Products by Stage of Development
Biopsy Devices Companies and Product Overview
Actuated Medical Inc Company Overview
Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table HydroMARK Plus Breast Biopsy Site Marker - Product Status
Table HydroMARK Plus Breast Biopsy Site Marker - Product Description
Table Devicor Medical Products Inc - Ongoing Clinical Trials Overview
Table HydroMARK Plus Breast Biopsy Site Marker - Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024
Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
Jun 13, 2024: Medtronic Confirms Global Layoffs
Jun 04, 2024: Endodrill Is Recognized as a Promising New Product for Solving a Significant Clinical Problem in a Medical Journal
May 17, 2024: Successful Case Studies with Endodrill GI Continue in Norway and Sweden
May 07, 2024: Broncus Medical Receives 510(K) Clearance For BioStar cTBNA/EBUS-TBNA Needle
Apr 30, 2024: EndoDrill presented as New Kid on the Block at ESGE Days
Apr 26, 2024: Elekta Instrument Recalls Disposable Biopsy Needle Kit for Leksell Stereotactic System for Possibly Containing Microscopic Stainless Steel Debris on the inside of the Biopsy Needle
Apr 18, 2024: BiBB Receives Patent Approval for EndoDrill in India
Apr 17, 2024: Successful clinical pilot study with EndoDrill GI published in peer reviewed scientific journal
Apr 05, 2024: First clinical cases with EndoDrill GI successfully performed at Karolinska University Hospital in Sweden
Mar 25, 2024: Stony Brook Professor George Leibowitz Assumes Role from Interim Dean Richard L. Edwards
Mar 18, 2024: In ongoing commitment to patients, Cook Medical announces new pediatric indication for the shorter Liver Access Biopsy Set
Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
Mar 02, 2024: Honey & Barry Sherman Legacy Foundation Donates $1 Million to Scarborough Health Network to Innovate Diagnostic Imaging
Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors
Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
Feb 21, 2024: Japanese Patent Office Issues Decision to Grant Patent for EndoDrill Technology
Feb 15, 2024: UC Davis Health Reports Positive Clinical Experiences with Endodrill GI
Feb 07, 2024: Bibb Receives European CE Mark Approval According to MDR for the Entire Endodrill Product Family
Feb 05, 2024: A Gynecology Instrument Designed to Improve Cervical Cancer Patient Outcomes Now Available in the US
Feb 02, 2024: First US Clinical Cases Successfully Conducted with EndoDrill GI
Jan 29, 2024: Canyon Medical Receives 510(K) Clearance For SureCore Automatic Disposable Biopsy Needle
Jan 29, 2024: Canyon Medical Receives Additional FDA 510(k) Clearance for SureCore Semi-Automatic Disposable Biopsy Needle
Jan 29, 2024: Canyon Medical Receives Additional FDA 510(k) Clearance for SureAim Coaxial Biopsy Needle
Jan 26, 2024: Devicor Medical Products Receives FDA 510(k) Clearance for LumiMARK Biopsy Site Marker
Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
Jan 04, 2024: Hologic to Announce Financial Results for the First Quarter of Fiscal 2024 on Thursday, February 1, 2024
Dec 26, 2023: Beijing ZKSK Technology Receives 510(k) Clearance for Disposable Hot Biopsy Forceps
Dec 14, 2023: Uro-1 Receives FDA 510(k) Clearance for SUREcore Prime Biopsy Instrument
Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
Oct 17, 2023: Praxis Medical Announces FDA Clearance of the EndoCore EBUS-TBNA Biopsy Device
Oct 11, 2023: Praxis Medical Devices Receives 510(K) Clearance for EndoCore
Oct 09, 2023: Stryker to Host Investor Day
Oct 05, 2023: LUMINELLE Announces China National Intellectual Property Administration's Decision to Grant Issuance of Patent for LUMINELLE Bx (Biopsy) System, Expanding Global Footprint
Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President
Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023
Sep 12, 2023: Limaca receives clearance from US FDA for biopsy device
Sep 06, 2023: TransMed7 Announces First Revenue from Concorde Family of Devices
Sep 05, 2023: Bibb Receives Approval of Two Patents in Europe for Endodrill
Aug 29, 2023: Coloplast Launches Offering to Raise Around Dkk 9 Billion Through Issue of New B Shares in a Directed Issue and Private Placement
Aug 29, 2023: Alpenglow Biosciences Presents the 3D Spatial Summit, an inaugural event for the field of 3D Spatial Biology to take place on September 21, 2023 in Cambridge, Massachusetts
Aug 21, 2023: Mammotome Launches the HydroMARK Plus Breast Biopsy Site Marker, an Innovation for Tissue Marker Displacement
Aug 15, 2023: Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2023 at High End of Investor Day Guidance